Alkyne-betaAG-TOCA, an octreotide derivative, targets somatostatin receptor type 2 (SST2)[1]. Alkyne-betaAG-TOCA can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
Molecular Weight:
1100.22
Purity:
98.99
Formula:
C48H65N11O15S2
Target:
Somatostatin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted